Anne Moxhon

Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).

J. Machiels, S. Schmitz, E. Bompas, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of sunitinib in recurrent or metastatic squamous cell carcinoma of the head and neck: GORTEC 2006-01.

J. Machiels, N. Michoux, S. Faivre, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: results of a prospective randomized study.

F. Richard, A. Moxhon, P J Van Cangh, 1998, The Journal of urology.

Phase I study of sorafenib in combination with docetaxel and prednisone in chemo-naïve patients with metastatic castration-resistant prostate cancer

J. Machiels, J. Canon, S. Oudard, 2012, Cancer Chemotherapy and Pharmacology.

Panitumumab as a radiosensitizing agent in KRAS wild-type locally advanced rectal cancer

C. Sempoux, J. Machiels, K. Haustermans, 2015, Targeted Oncology.

Prospective randomized study comparing docetaxel, estramustine, and prednisone with docetaxel and prednisone in metastatic hormone-refractory prostate cancer.

J. Machiels, B. Tombal, B. Filleul, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.